NASDAQ: BVS
Bioventus Inc Stock Ownership - Who owns Bioventus?

Insider buying vs selling

Have Bioventus Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Anthony DadamioSVP General Counsel2025-04-112,958$7.57
$22.39kSell
Katrina J. ChurchSVP Chief Compliance Officer2025-04-111,283$7.57
$9.71kSell
Mark Leonard SingletonSVP CFO2025-04-113,875$7.57
$29.33kSell
Mark Leonard SingletonSVP CFO2025-03-245,479$9.79
$53.64kSell
Anthony DadamioSVP General Counsel2025-03-172,615$9.75
$25.50kSell
Katrina J. ChurchSVP Chief Compliance Officer2025-03-171,018$9.75
$9.93kSell
Anthony DadamioSVP General Counsel2025-02-184,380$10.19
$44.63kSell
Katrina J. ChurchSVP Chief Compliance Officer2025-02-181,537$10.19
$15.66kSell
Mark Leonard SingletonSVP CFO2025-02-186,498$10.19
$66.21kSell
Robert E. ClaypoolePresident and CEO2025-01-1328,786$9.10
$261.95kSell

1 of 2

BVS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BVS insiders and whales buy or sell their stock.

BVS Shareholders

What type of owners hold Bioventus Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Smith Nephew PLC20.00%16,534,814$118.55MInsider
Juniper Investment Company LLC15.93%13,168,697$94.42MInsider
Martin P. Sutter15.85%13,106,565$93.97MInsider
Ew Healthcare Partners Acquisition Fund LP15.75%13,021,324$93.36MInsider
Essex Woodlands Management Inc15.75%13,021,324$93.36MInstitution
John A. Bartholdson8.49%7,018,977$50.33MInsider
Juniper Investment Company LLC8.39%6,939,357$49.76MInstitution
Nantahala Capital Management LLC6.39%5,280,842$37.86MInstitution
Spindletop Healthcare Capital LP4.72%3,906,395$28.01MInsider
David J. Parker3.94%3,255,332$23.34MInsider

1 of 3

BVS vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BVS37.59%62.41%Net Selling
PMI0.00%0.00%
AVNS95.69%4.31%Net SellingNet Buying
OFIX77.98%22.02%Net BuyingNet Selling
ZIMV85.73%12.44%Net SellingNet Selling

Bioventus Stock Ownership FAQ

Who owns Bioventus?

Bioventus (NASDAQ: BVS) is owned by 58.52% institutional shareholders, 97.18% Bioventus insiders, and 0.00% retail investors. Smith Nephew PLC is the largest individual Bioventus shareholder, owning 16.53M shares representing 20.00% of the company. Smith Nephew PLC's Bioventus shares are currently valued at $113.10M.

If you're new to stock investing, here's how to buy Bioventus stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.